Episode
Can a DNA test help your heart health?
- Podcast
- All Access DNA
- Published
- Nov 11, 2025
- Duration seconds
- 2761
- Processing state
not_requested- Canonical source
- https://allaccessdna.podbean.com/e/heartdisease_cardio/
Actions
POST https://stenobird.com/v1/public/podcasts/all-access-dna-7139504/episodes/can-a-dna-test-help-your-heart-health/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/all-access-dna-7139504/can-a-dna-test-help-your-heart-health.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Heart disease and lack of genetic testing. In this conversation, Ana Morales discusses the critical signs of genetic heart disease, particularly focusing on early onset conditions and the importance of recognizing red flags such as elevated cholesterol and complications during/after pregnancy. She emphasizes that these health issues should not be ignored and highlights the need for awareness and proactive health management. Key Takeaways: Having early onset heart disease of any kind is not normal. Early onset is defined as less than age 60. Severely elevated cholesterol, especially if it runs in families, is concerning. Onset of heart disease during or soon after pregnancy is a red flag. Thoracic aortic aneurysm at any age should not be ignored. Over 95% of people who have a genetic heart condition have not had genetic testing. Hereditary cardiac disease is underdiagnosed. Proactive health management can save lives. Ana Morales is an Associate Professor at the Geisinger Department of Genomic Health, a board-certified genetic counselor, and a Translational Health Sciences Ph.D. candidate. Her dissertation, titled "Development of a Guideline-Based Innovation to Support the Genetic Evaluation of Cardiomyopathy and Arrhythmia: An Exploratory Mixed Methods Study," aims to address existing guideline gaps by developing an implementation plan for an innovation designed to support the genetic evaluation of cardiomyopathy and arrhythmia. Ana's prior work includes evaluating genetic testing utilization, highlighting the underutilization of cardiomyopathy genetic testing. She has also contributed to key literature, including co-authoring the American College of Medical Genetics and Genomics/Heart Failure Society of America guideline on the genetic evaluation for cardiomyopathy and…